Back

Reduction of LDL-C-related residual cardiovascular risk with ezetimibe: are mechanistic considerations warranted in practice?

European Heart Journal

19 May 2017
Organised by: Logo
Read full article
ESC Journals PREVENTIVE CARDIOLOGY Risk Factors and Prevention
You may be interested in
thumbnail
Congress Presentation
Coronary risk reduction intervention for siblings and offspring of patients with premature coronary heart disease: the criso project.
thumbnail
ESC TV Today
Episode 26: Lp(a): the future starts now - Myocardial infarction in older age and frailty
thumbnail
Webinar
Risk assessment and lipid management in primary prevention

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources